NCT05847790 (REACTIVE) is a NA clinical trial of Invu monitoring belt in Fetal Monitoring, sponsored by University of Pennsylvania.

Who is sponsoring NCT05847790?

NCT05847790 is sponsored by University of Pennsylvania.

What drugs are being tested in NCT05847790?

Interventions in NCT05847790: Invu monitoring belt, Standard of care.

What condition does NCT05847790 study?

NCT05847790 studies Fetal Monitoring.

Is NCT05847790 still recruiting?

NCT05847790 is currently completed. Last updated 30 October 2025.

Last reviewed 2025-10-30 · How we verify

NCT05847790: REACTIVE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Remote Pregnancy Monitoring to Improve Access

Completed NA Last updated 30 October 2025

What this trial tests

NA trial testing Invu monitoring belt in Fetal Monitoring in 400 participants. Completed in 26 September 2025.

Timeline

25 May 2023

Primary endpoint
26 September 2025

26 September 2025

Quick facts

Lead sponsor	University of Pennsylvania
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	400
Start date	25 May 2023
Primary completion	26 September 2025
Estimated completion	26 September 2025
Sites	1 location across United States

Drugs / interventions tested

Invu monitoring belt
Standard of care

Conditions studied

Fetal Monitoring — all drugs for Fetal Monitoring →

Sponsor

University of Pennsylvania

Who can join

Eligibility, female only, with Fetal Monitoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to determine the effectiveness of remote nonstress test (NST) compared to in-clinic NSTs in improving fetal testing completion rates. Participants will be randomized to either in-clinic NSTs or use of an FDA-approved remote monitoring belt for their pregnancy monitoring.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Use of a wireless monitoring device to perform nonstress tests from home: the patient perspective.
Hamm RF, Steele MC, O'Brien C, Gebru H, et al · · 2024 · cited 2× · PMID 38460825 · DOI 10.1016/j.ajogmf.2024.101342

Verify or expand the search:

Other recruiting trials for Fetal Monitoring

Currently open trials in the same condition.

NCT06893510 — Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With Preeclampsia · NA · recruiting

Other University of Pennsylvania trials

Trials by the same sponsor.

NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05847790 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
Last refreshed: 30 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05847790.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing